Neslihan Tinastepe

Dr. Neslihan Tinastepe

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 July 2020 in Journal of Esthetic and Restorative Dentistry
Verified
Journal Article
Closed access
PDF file
NTNeslihan Tinastepe
Neslihan Tinastepe
OMOzlem Malkondu
Ozlem Malkondu
IIIpek Iscan
Ipek Iscan
Ender KazazogluEnder Kazazoglu
Ender Kazazoglu

1 January 2013 in Ağrı - The Journal of The Turkish Society of Algology
Verified
Journal Article
Closed access
NTNeslihan Tinastepe
Neslihan Tinastepe
KOKoray Oral
Koray Oral
The head and neck regions are the most common sites of the human body to be involved in chronic pain conditions. Neuropathic pain is a chronic pain condition, and refers to all pain initiated or caused by a primary lesion or dysfunction or transitory perturbation in the peripheral or central nervous system (CNS). Trigeminal neuralgia, atypical odontalgia (phantom tooth pain), burning mouth syndrome, traumatic neuropathies, postherpetic neuralgias and complex regional pain syndrome are neuropathic pain conditions in the orofacial region that can be encountered in pain and dental clinics. The majority of the time this problem is misdiagnosed by the dentist, which can lead to unnecessary treatments. These treatments may include endodontic treatment and extraction of the tooth or teeth in the region. In this review, only post-traumatic peripheral pain neuropathies seen after dental treatments will be discussed.

3 January 2023 in The Journal of Prosthetic Dentistry
Verified
Journal Article
Closed access
NTNeslihan Tinastepe
Neslihan Tinastepe
OMOzlem Malkondu
Ozlem Malkondu
Ender KazazogluEnder Kazazoglu
Ender Kazazoglu

4 July 2015 in Cranio®
Verified
Journal Article
Closed access
NTNeslihan Tinastepe
Neslihan Tinastepe
BKBurcu Bal Küçük
Burcu Bal Küçük
KOKoray Oral
Koray Oral
Aims: Botulinum toxin, the most potent biological toxin, has been shown to be effective for a variety of disorders in several medical conditions, when used both therapeutically and cosmetically. In recent years, there has been a rising trend in the use of this pharmacological agent to control bruxing activity, despite its reported adverse effects. The aim of this review was to provide a brief overview to clarify the underlying essential ideas for the use of botulinum toxin in bruxism based on available scientific papers. Methodology: An electronic literature search was performed to identify publications related to botulinum toxin and its use for bruxism in PubMed. Hand searching of relevant articles was also made to identify additional studies. Results: Of the eleven identified studies, only two were randomized controlled trials, compared with the effectiveness of botulinum toxins on the reduction in the frequency of bruxism events and myofascial pain after injection. The authors of these studies concluded that botulinum toxin could be used as an effective treatment for reducing nocturnal bruxism and myofascial pain in patients with bruxism. Conclusion: Evidence-based research was limited on this topic. More randomized controlled studies are needed to confirm that botulinum toxin is safe and reliable for routine clinical use in bruxism.


31 March 2021 in Cranio®
Verified
Journal Article
Closed access
NTNeslihan Tinastepe
Neslihan Tinastepe
IIIpek Iscan
Ipek Iscan
To evaluate the possible relationship between bruxism and smartphone overuse and assess the potential role of anxiety and depression in this relationship. The null hypothesis was that there was no ...